ATProto Browser

{
  "text": "I’ll never understand how a study like this gets through peer review. While GLP-1RA & SGLT2i meds are pretty amazing, they can’t decrease risk for dementia the moment you get a prescription. That’s a clear signal that the groups are different at baseline. #medsky\njamanetwork.com/journals/jam...",
  "$type": "app.bsky.feed.post",
  "embed": {
    "$type": "app.bsky.embed.images",
    "images": [
      {
        "alt": "",
        "image": {
          "$type": "blob",
          "ref": {
            "$link": "bafkreidk755zui255bz5dckauzwfuvn4qbz6762bpmapxw4ac4naffxgba"
          },
          "mimeType": "image/jpeg",
          "size": 237550
        },
        "aspectRatio": {
          "width": 1290,
          "height": 889
        }
      }
    ]
  },
  "langs": [
    "en"
  ],
  "facets": [
    {
      "index": {
        "byteEnd": 269,
        "byteStart": 262
      },
      "features": [
        {
          "tag": "medsky",
          "$type": "app.bsky.richtext.facet#tag"
        }
      ]
    },
    {
      "index": {
        "byteEnd": 301,
        "byteStart": 270
      },
      "features": [
        {
          "uri": "https://jamanetwork.com/journals/jamaneurology/article-abstract/2831976",
          "$type": "app.bsky.richtext.facet#link"
        }
      ]
    }
  ],
  "createdAt": "2025-04-08T09:01:33.921Z"
}